BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...

October 04, 2023 | News

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...

September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | News

Takara Bio Europe Launches Enzymes for mRNA Vaccine R&D

Takara Bio Europe (TBE) announced the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatas...

September 13, 2023 | News

Serbian Prime Minister Visits SK Bioscience for Vaccine Localization Partnership

Ana Brnabić, Prime Minister of Serbia visited the headquarters of SK bioscience. SK bioscience has signed a Memorandum of Understanding with th...

September 11, 2023 | News

ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001

Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...

September 06, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

Under the MOU, both parties agreed to cooperate for a successful supply of the vaccine. While Eubiologics, a developer and producer of Euvichol, takes char...

August 28, 2023 | News

EU Commission Approves Pfizer's ABRYSVO™ for Infant and Elderly RSV Protection

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...

August 25, 2023 | News

SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...

August 24, 2023 | News

Satio Partners with BARDA DRIVe for Patch-Based Ebola Diagnostic

This groundbreaking diagnostic will combine Satio's patch-based blood collection device with Institut Pasteur de Dakar's sensitive and rapid...

August 21, 2023 | News

Nagasaki University & NEC OncoImmunity Partner for Universal Vaccines Against Tropical Diseases

The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs to be universally and broadly pr...

August 21, 2023 | News

Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong

First pneumococcal conjugate vaccine that fights against 20 serotypes leading to most of the invasive pneumococcal diseases and pneumonia[2],[3] &md...

August 11, 2023 | News

SK bioscience Announces Equity Investment in Novavax to Strengthen Strategic Partnership

SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation and strengthen their strategic partnership. SK bioscien...

August 09, 2023 | News

Stay Connected